S&P Capital IQ Focus Stock of the Week: Xilinx Inc.

SP Capital IQ  |

S&P Capital IQ Equity Analyst Christin Armacost has a 5-STARS  "Strong Buy" recommendation for Xilinx Inc (XLNX) .  For more information, please visit:  www.marketscope.com

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
XLNX Xilinx Inc. 90.54 2.41 2.73 2,398,506 Trade
SBGGF Consolidated Growth Holdings Ltd 0.00 0.00 0.00 0

Comments

What Is Petrolithium?

MGX Minerals explains the advantages of petrolithium and how they are helping to solve future problems today.

Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.